The strategic move is aimed at integrating automated, high-throughput gene synthesis into Regeneron's in-house laboratories.

To help address the impact of COPD on patients and communities, global healthcare companies Sanofi and Regeneron are working together to study the ripple effects of COPD and to help create a ...